GE HealthCare's Heart Health Boost: Deals and FDA Go-Aheads

GE HealthCare's stock jumped nearly 3% after announcing a deal to expand access to its heart imaging agent, Flyrcado, and FDA clearance for its AI-powered Revolution Vibe CT scanner. While the initial surge cooled off, the news highlights how strategic moves in health tech can still excite investors, even as the stock remains below its peak and the focus stays on AI-driven tech giants. Hosted on Acast. See acast.com/privacy for more information.